Cargando…
Screening strategies to identify HSP70 modulators to treat Alzheimer’s disease
Alzheimer’s disease, the most common type of dementia, is a progressive brain disease that destroys cognitive function and eventually leads to death. In patients with Alzheimer’s disease, beta amyloids and tau proteins form plaques/oligomers and oligomers/tangles that affect the ability of neurons t...
Autores principales: | Repalli, Jayanthi, Meruelo, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4294646/ https://www.ncbi.nlm.nih.gov/pubmed/25609918 http://dx.doi.org/10.2147/DDDT.S72165 |
Ejemplares similares
-
Translocator Protein (TSPO) Role in Aging and Alzheimer’s Disease
por: Repalli, Jayanthi
Publicado: (2014) -
Synthetic Small Molecule Modulators of Hsp70 and Hsp40 Chaperones as Promising Anticancer Agents
por: Nitzsche, Bianca, et al.
Publicado: (2023) -
Hsp70 in Redox Homeostasis
por: Zhang, Hong, et al.
Publicado: (2022) -
Involvement of heat shock proteins HSP70 in the mechanisms of endogenous neuroprotection: the prospect of using HSP70 modulators
por: Belenichev, Igor F., et al.
Publicado: (2023) -
HSP70 Multi-Functionality in Cancer
por: Albakova, Zarema, et al.
Publicado: (2020)